SensoDX II, LLC
Houston, United States · Founded 2016 · $868K raised
- Headquarters
- Houston, Texas
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Total Funding
- $868K
- Last Round
- $868K GrantJan 2017
- Rounds
- 1
About
SensoDX II develops programmable bio-nano-chip technology for point-of-care diagnostics across cardiac disease, cancer (oral, ovarian, prostate), trauma, and drugs of abuse. The platform integrates mobile health interfaces to deliver test results directly to patients and healthcare providers without centralized lab infrastructure.
Summary
SensoDX II, LLC is a Biotech company based in Houston, United States, founded in 2016. It has raised $868K in total across 1 round, most recently a $868K Grant round in Jan 2017. Investors include NIH.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2017
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.